Today, reliable diagnosis of infectious diseases is not available at the Point-Of-Care, when most needed, resulting in Antimicrobial Resistance, High Treatment Costs and Patients’ Dissatisfaction. A growing number of infectious ag...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
REVERSE
pREVention and management tools for rEducing antibiotic Resi...
14M€
Cerrado
AntibioDx
AntibioDx A groundbreaking in vitro diagnostic device with...
71K€
Cerrado
DRAIGON
Diagnosing Infections with Multi-Drug Resistant Microorganis...
7M€
Cerrado
ResisTEST
Developing a rapid diagnostic kit for antibiotic resistance
150K€
Cerrado
TAILORED-TREATMENT
DEVELOPMENT OF TAILORED ANTIMICROBIAL TREATMENT REGIMENS AND...
8M€
Cerrado
RTI2018-094832-B-I00
SISTEMA DE AYUDA A LA DECISION CLINICA PARA VIGILANCIA DE IN...
124K€
Cerrado
Información proyecto EDAS HEALTHCARE
Duración del proyecto: 3 meses
Fecha Inicio: 2019-11-20
Fecha Fin: 2020-02-29
Líder del proyecto
EDAS HEALTHCARE LTD
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Today, reliable diagnosis of infectious diseases is not available at the Point-Of-Care, when most needed, resulting in Antimicrobial Resistance, High Treatment Costs and Patients’ Dissatisfaction. A growing number of infectious agents – such as pneumonia, tuberculosis, and salmonellosis – with every day are becoming harder to identify and treat correctly without laboratory tests, is the main cause for a massive scale of misuse and overuse of antibiotics. Approximately 30% to 50% of antibiotic use in humans is inappropriate or even unnecessary. Due to lack of diagnosis available (Time-consuming, cost, absence of infrastructure) physicians commonly prescribe antibiotics based on symptoms. However, this approach does not allow to distinguish if the disease is caused by bacteria or viruses on which drug will work and which won't. At EDAS HEALTHCARE, patent approved technology, resulting 5 years of research, developed a data-driven infectious disease diagnosis system that enables the identification of pathogens in real-time. The use of epidemiology and location-based diagnosis combined with big-data & machine learning algorithms results in over 85% accuracy (a case study results). At a fraction of the cost of laboratory tests EDAS Healthcare can provide decision support system to all physicians at any primary care service upon the first patient encounter with the ER or GP or Telemedicine, and help instantly predict the causative agent of infectious diseases (9 different viruses and 5 different bacteria to date). Targeting the infectious disease diagnostic market worth €6Bn p.a. we offer a solution for hospitals ER, Telemedicine, Homecare, and surveillance agencies. Some of them already confirmed their interest in using our service. Within the Phase 1 project we aim at preparing plans for a wide-scale clinical trials, revise our IPR protection strategy and refine our current business model.